TY - JOUR
T1 - Perioperative Anemia Management
AU - Abeysiri, Sandaruwani
AU - Chau, Marisa
AU - Richards, Toby
N1 - Funding Information:
Dr. Richards reports grants from the National Institute for Health Research (NIHR) Health Technology Assessment, National Health and Medical Research Council, National Institute of Academic Anaesthesia BJA/ACTA/VASGBI; grants, personal fees, and nonfinancial support from Pharmacosmos, Vifor Pharma; grants and personal fees from Acelity; grants from NIHR Efficacy and Mechanism Evaluation; personal fees from Amgen, Medtronic, and Tiash Ltd., outside the submitted work. He is a regular speaker at national and international conferences on anemia, blood transfusion, wound healing, and vascular diseases for which he has received expenses for travel, accommodation, and sundries. He has worked with several agencies promoting meetings or health care. He is the director of the Iron Clinic Ltd. and Veincare London Ltd. He is also the vascular lead for 18-week wait Ltd. Dr. Abeysiri reports personal fees and other fees toward a conference from Vifor Pharma, outside the submitted work.
Publisher Copyright:
© 2020 Royal Society of Chemistry. All rights reserved.
PY - 2020
Y1 - 2020
N2 - Anemia is increasingly recognized as an interventional hematological target in patients before major surgery. Preoperative anemia increases the need for perioperative blood transfusion, and there is now a well-recognized association with increased patient complications, length of hospital stay, and worse outcomes. Patient Blood Management (PBM) is a World Health Organization endorsed, evidence-based management bundle of care in transfusion hemostasis that focuses on three main aspects: anemia management, prevention of blood loss, and appropriate transfusion practice. Implementation of PBM guidelines has been accompanied by reduced transfusion needs and improved patient outcomes. In a patient presenting with preoperative anemia or at risk of transfusion, this should initiate a program of PBM that manages the patient through the entire operative period. We review the current evidence on the three pillars of PBM and highlight those aspects with the strongest evidence in support of their impact.
AB - Anemia is increasingly recognized as an interventional hematological target in patients before major surgery. Preoperative anemia increases the need for perioperative blood transfusion, and there is now a well-recognized association with increased patient complications, length of hospital stay, and worse outcomes. Patient Blood Management (PBM) is a World Health Organization endorsed, evidence-based management bundle of care in transfusion hemostasis that focuses on three main aspects: anemia management, prevention of blood loss, and appropriate transfusion practice. Implementation of PBM guidelines has been accompanied by reduced transfusion needs and improved patient outcomes. In a patient presenting with preoperative anemia or at risk of transfusion, this should initiate a program of PBM that manages the patient through the entire operative period. We review the current evidence on the three pillars of PBM and highlight those aspects with the strongest evidence in support of their impact.
KW - anemia
KW - blood loss
KW - Patient Blood Management
KW - perioperative anemia
KW - transfusion
UR - http://www.scopus.com/inward/record.url?scp=85079021176&partnerID=8YFLogxK
U2 - 10.1055/s-0039-1697933
DO - 10.1055/s-0039-1697933
M3 - Article
C2 - 31614387
AN - SCOPUS:85079021176
SN - 0094-6176
VL - 46
SP - 8
EP - 16
JO - Seminars in Thrombosis and Hemostasis
JF - Seminars in Thrombosis and Hemostasis
IS - 1
ER -